Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nurysh is an evidence-based clinical skincare and beauty technology company founded in 2016 as a subsidiary of Uplevity. The company specializes in developing clinically validated skincare products and non-invasive anti-aging devices, most notably the Lyft 2.0, which holds FDA Class II clearance for treating acne and wrinkles. Nurysh's technology portfolio integrates microcurrent, galvanic, and LED light therapy designed to stimulate dermal activity and improve skin texture, firmness, and hydration. Based in the United States, the brand focuses on providing professional-grade aesthetic solutions for at-home use, bridging the gap between clinical treatments and consumer skincare routines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nurysh.